SCHEMBL29656131

SCHEMBL29656131

O=S([O-])OS(=O)[O-].O=S([O-])OS(=O)[O-].[C+4]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29975565 0.91
SCHEMBL30444408 0.91
SCHEMBL29569143 0.91
SCHEMBL625585 0.91
Potassium Ion SCHEMBL723618 0.91
Lithium Ion SCHEMBL3365004 0.91
SCHEMBL30722367 0.91
SCHEMBL31310289 0.91
SCHEMBL30595827 0.91
SCHEMBL30287272 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4029935-A1 S. EUBAYANUS STRAIN AND HYBRIDS THEREOF Carlsberg A/S (DK) 2022-07-20 EP disclosed
US-20220213062-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION PMV PHARMACEUTICALS, INC. 2022-07-07 US disclosed
US-11339141-B2 Methods and compounds for restoring mutant p53 function PMV PHARMACEUTICALS, INC. (US) 2022-05-24 US disclosed